ASO Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Operational Resilience ATAT Q1 2026 Earnings EPS Surges Past Estimates Stock Declines Despite Strong Beat TE Connectivity Q1 2026 Earnings Modest EPS Beat Amid Steady Operational Execution NRX Pharmaceuticals Q1 2026 Earnings Wider Loss Despite No Revenue Stock Advances PRTS Q1 2026 Earnings EPS Surprises with 4885 Beat Stock Falls 392 MTRN Q1 2026 Earnings EPS Surpasses Estimates Amid Muted Stock Response